Chemotherapeutic engineering: Concept, feasibility, safety and prospect-a tribute to shu chien's 80th birthday

Cellular and Molecular Bioengineering

Volumn 4, Issue 4, 2011, Pages 708-716

  Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anticancer drugs; Cancer nanotechnology; Controlled release; Drug delivery; Future medicine; Nanomedicine

Indexed keywords

CYCLOSPORIN A; DOCETAXEL; LIPOSOME; PACLITAXEL; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; PRODRUG;

ARTICLE; BIOENGINEERING; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CELLULAR BIOENGINEERING; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; FEASIBILITY STUDY; HUMAN; IC 50; MEDICAL LITERATURE; MICELLE; MOLECULAR BIOENGINEERING; NANOTECHNOLOGY; PRIORITY JOURNAL; SAFETY;

EID: 84856409632     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-011-0198-3     Document Type: Article

References (29)

1. Cao, N., and S. S. Feng. Doxorubicin conjugated to D-atocopheryl polyethylene glycol 1000 succinate (TPGS): in vitro cytotoxicity, in vivo pharmacokinetics and biodistribution. Biomaterials 29(28):3856-3865, 2008.
2. Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet II 82:445-451, 1913.
3. Feng, S. S. Snapshot: nanoparticles of biodegradable polymers for cancer diagnosis and treatment (the first-ever SnapShot of the journal). Biomaterials 29(30):4146-4147, 2008.
4. Feng, S. S., and S. Chien. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58:4087-4114, 2003; (The Most Cited Paper Award 2003-2006). (Pubitemid 37164365)
5. Feng, S. S., and G. F. Huang. Effects of phospholipids as emulsifiers on controlled release of Paclitaxel from nanospheres of biodegradable polymers. J. Control. Release 71:53-69, 2001.
6. Feng, S. S., L. Y. Zhao, Z. P. Zhang, G. Bhakta, K. Y. Win, Y. C. Dong, and S. Chien. Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable Paclitaxel chemotherapy for 168 hours in vivo. Chem. Eng. Sci. 62:6641-6648, 2007. (Pubitemid 47610671)
7. Feng, S. S., L. Mei, P. Anitha, C. W. Gan, and W. Y. Zhou. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 30(19):3297-3306, 2009.
8. Feng, S. S., L. Y. Zhao, and J. T. Tang. Editorial: nanomedicine for oral chemotherapy. Nanomedicine (UK) 6(3):407-410, 2011.
9. Gan, C. W., and S. S. Feng. Transferrin-Conjugated Nanoparticles of Poly(lactide)-D-A-Tocopheryl Polyethylene Glycol Succinate Diblock Copolymer for Targeted Drug Delivery across the Blood-Brain Barrier. Biomaterials 31(30):7748-7757, 2010.
10. Gan, C. W., S. Chien, and S. S. Feng. Enhancement of chemotherapeutical efficacy of Docetaxel by using a biodegradable nanoparticle formulation. Curr. Pharm. Des. 16(21):2308-2320, 2010.
11. Kulkarni, S. A., and S. S. Feng. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Nanomed. Nanotechnol. Biol. Med., Submitted, 2010.
12. Liu, Y. T., K. Li, J. Pan, B. Liu, and S. S. Feng. Folic acid conjugated nanoparticles of mixed-lipid-monolayer shell and biodegradable-polymer-core for targeted delivery of Docetaxel. Biomaterials 31(2):330-338, 2010.
13. Liu, Y. T., K. Li, B. Liu, and S. S. Feng. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 31(35):9145-9155, 2010.
14. Mi, Y., Y. T. Liu, and S. S. Feng. Formulation of Docetaxel by folic acid-conjugated d-a-tocopheryl polyethylene glycol succinate 2000 (vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 32(16):4058-4066, 2010.
15. Mu, L., and S. S. Feng. Vitamin E TPGS used as emulsifier in the solvent extraction/evaporation technique for fabrication of polymeric nanospheres for controlled release of Paclitaxel. J. Control. Release 80:129-144, 2002. (Pubitemid 34273754)
16. Muthu, M. S., S. A. Kulkarni, J. Q. Xiong, and S. S. Feng. D-alpha-tocopheryl polyethylene glycol 1000 succinate coated liposomes enhanced cellular uptake and cytotoxicity of Docetaxel in brain cancer cells. Biomaterials, in press, 2011.
17. Pan, J., and S. S. Feng. Folate-decorated poly (lactide)-vitamin E TPGS nanoparticles for targeted delivery of Paclitaxel. Biomaterials 29:2663-2672, 2008.
18. Pan, J., and S. S. Feng. Targeting and imaging cancer cells by folate decorated, quantum dots loaded nanoparticles of biodegradable polymers. Biomaterials 30:1176-1183, 2009.
19. Pan, J., Y. T. Liu, and S. S. Feng. A preliminary research on multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine (UK) 5(3):347-360, 2010.
20. Sun, B. F., and S. S. Feng. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of Docetaxel. Nanomedicine (UK) 4(4):431-445, 2009.
21. Tan, Y. F., P. Chandrasekharan, D. Maity, X. Y. Cai, K. H. Chuang, Y. Zhao, S. Wang, J. Ding, and S. S. Feng. Multimodal tumor imaging by iron oxides (IOs) and quantum dots (QDs) formulated in poly(lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate (PLA-TPGS) nanoparticles. Biomaterials 32(11):2969-2978, 2010.
22. Vanangamudi, A., N. Cao, and S. S. Feng. Targeted delivery of Doxorubicin conjugated to folic acid and D-atocopheryl polyethylene glycol succinate (TPGS). J. Biomed. Mater. Res. A 94A(3):730-743, 2010.
23. Wang, Y., Y. W. Ng, Y. Chen, B. Shuter, J. B. Yi, J. Ding, S. C. Wang, and S. S. Feng. Formulation of superparamagnetic iron oxides (IOs). by nanoparticles of biodegradable polymers for Magnetic Resonance Imaging (MRI). Adv. Funct. Mater. 18(2):308-318, 2008. (Pubitemid 351212312)
24. Win, K. Y., and S. S. Feng. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26(15):2713-2722, 2005.
25. Win, K. Y., and S. S. Feng. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for clinical administration of Paclitaxel. Biomaterials 27:2285-2291, 2006. (Pubitemid 41774539)
26. Zhang, Z. P., and S. S. Feng. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 27(2):262-270, 2006a.
27. Zhang, Z. P., and S. S. Feng. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of Paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27(21):4025-4033, 2006b.
28. Zhang, Z. P., S. H. Lee, C. W. Gan, and S. S. Feng. Pharmacokinetics, biodistribution and xenograft tumor model of PLA-TPGS nanoparticles prepared by dialysis method for controlled and sustained small molecule chemotherapy. Pharm. Res. 25(8):1925-1935, 2008.
29. Zhao, L. Y., J. T. Tang, and S. S. Feng. Editorial: nanothermotherapy by high performance magnetic nanoparticles. Nanomedicine (UK) 5(9):1305-1308, 2010.